Keyphrases
Neoadjuvant Therapy
66%
Pancreatic Ductal Adenocarcinoma
66%
Microsatellite Instability-high (MSI-H)
66%
Programmed Death-ligand 1 (PD-L1)
66%
PD-L1 Expression
41%
Histological Subtypes
38%
Overall Survival Rate
38%
Pancreatic Cancer
38%
HER2 Amplification
35%
Overall Survival
33%
Prognostic Indicator
33%
Cancer Patients
33%
Surgical Outcomes
33%
Patient Survival
33%
Positive Lymph Nodes
33%
Clinicopathological Analysis
33%
Colorectal Neuroendocrine Carcinoma
33%
Pancreaticoduodenectomy
33%
Adenosquamous Carcinoma of the Pancreas
33%
Colorectal Cancer
33%
CDX2
33%
Mucin 1 (MUC1)
33%
Grading Scheme
33%
Gallbladder
33%
Primary Colorectal Cancer
33%
Ampullary Adenocarcinoma
33%
Single-center Study
33%
Immunohistochemical Analysis
33%
Node-positive
33%
Tumor Regression Grade
33%
Gallbladder Cancer
33%
Neuroendocrine Carcinoma
33%
Epstein-Barr Virus Infections
33%
Gastric Carcinoma with Lymphoid Stroma
33%
Epstein-Barr Virus
33%
Multivariate Analysis
32%
Histologic
28%
Human Epidermal Growth Factor Receptor 2 (HER2)
26%
Tumor
24%
Growth Pattern
22%
Disease-free Survival
22%
Independent Prognostic Factor
21%
Histology
16%
Survival Analysis
16%
Lymph Node Ratio
16%
T Category
16%
YpN0
16%
Poor Survival
11%
Postoperative Adjuvant Chemotherapy
11%
Organoids
11%
Medicine and Dentistry
Overall Survival
100%
Microsatellite Instability
77%
Colorectal Carcinoma
66%
Neoadjuvant Therapy
66%
Neuroendocrine Carcinoma
66%
Programmed Death-Ligand 1
66%
Pancreas Adenocarcinoma
63%
Neoplasm
63%
Adenocarcinoma
55%
Survival Rate
47%
Pancreas Cancer
36%
Mucin 1
33%
Lymph Node
33%
Pancreaticoduodenectomy
33%
Prognostication
33%
Tumor Regression
33%
Adenosquamous Carcinoma
33%
Epstein Barr Virus
33%
Epstein-Barr Virus Infection
33%
Stomach Carcinoma
33%
Stroma
33%
Multivariate Analysis
31%
Disease Free Survival
26%
Diseases
23%
Prognostic Factor
22%
Lymph Duct
16%
Survival Analysis
14%
Distant Metastasis
14%
Next Generation Sequencing
14%
Histogenesis
11%
Adjuvant Therapy
11%
Nuclear Moulding
11%
Survival Time
11%
Large Cell
11%
Keratin 20
11%
Lymph Node Metastasis
11%
Neuroendocrine Differentiation
11%
APC
11%
Rosette Formation
11%
Organoid
11%
Malignant Neoplasm
11%
Surgery
11%
Keratin 7
11%
P16
11%
Intraepithelial Neoplasia
11%
Targeted Therapy
11%
Chemoradiation Therapy
11%
Pathologist
9%
Stomach Adenocarcinoma
8%
Protein P53
7%